Acadia Pharmaceuticals
P. Markus Dey has an extensive background in pharmacology, toxicology, and safety assessment, holding prominent positions in various prestigious organizations. Dey served as the Executive Director and Head of Nonclinical Safety Assessment at Acadia Pharmaceuticals Inc. from October 2020 to October 2021 and previously worked at Merck from April 2007 to November 2020 in roles including Director of Merck Research Laboratories and Senior Principal Scientist. Earlier experience includes a tenure as Research Scientist at Roche and an Assistant Professorship at Auburn University. Additionally, Dey has been an Adjunct Full Professor at Rutgers University since 2001, contributing to academia while also completing a postdoctoral fellowship in developmental neurobiology at Thomas Jefferson University. Dey is recognized as a recipient of the NIEHS F32 Fellowship Award.
This person is not in any teams
This person is not in any offices
Acadia Pharmaceuticals
3 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.